Photo: Immuno fluorescence at the Edinburgh lab

Emerging research and treatments

There's never been a more exciting time in MS research. On this page you can read the latest research into some of the most active areas of research.

> Visit our treatments in trials page for the latest clinical trials results for MS.

large group of members of Progressive MS Alliance

Progressive MS

Find out about the latest research into progressive MS, including our international collaboration, the Progressive MS Alliance.

> Find out what we're doing about progressive MS

Read about the Progressive MS Alliance
Photo: Inflammation and stem cells

Stem cells

Stem cells are hugely exciting. They are a key research tool and they’re being developed as treatments.

> Find out about HSCT

> Read about MSCT

Find out about how stem cells are used in research
Photo shows a researcher in a lab pipetting into a test tube

Genetics

Genetics is the study of our genes and how they might be linked to conditions like MS. We've learned a lot about how genes might influence the risk of developing MS. Researchers are using this to learn more about MS risk in families, and to help develop new treatments.
Find out about genes and MS

Vitamin D

We're learning a lot about the role that vitamin D plays in MS, but we still don’t know if taking vitamin D supplements could help to manage MS. Find out what we're doing to change this.
Read about our vitamin D research

Myelin repair

To stop MS we need to find treatments that repair the damage to the myelin coating around nerves. Read about the latest myelin repair research, including  clinical trials.
Find out about myelin repair research

Neuroprotection

If we can find drugs that can protect nerves from damage then we have the potential to stop MS getting worse, and even reverse disability for some people.
Find out how neuroprotection could help in MS

Other areas of research

A number of other topics have been investigated for their link to MS in the past. Find out more about some of these research areas.

> Find out about chronic cerebrospinal venous insufficiency (CCSVI)

> Find out about low-dose naltrexone (LDN)